Abstract
Because in most clinical trials of neurological drugs the goal is to demonstrate efficacy as quickly as possible while exposing the fewest possible patients to an ineffective drug, it is often necessary to perform a clinical trial at more than one site. A coordinating center plays a crucial role in such trials. The Epilepsy Branch of the National Institutes of Health has had considerable experience as a coordinator for clinical trials of antiepileptic drugs, and this chapter will be based on that experience.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Temkin O (1971). The Falling Sickness. A History of Epilepsy from the Greeks to the Beginnings of Modern Neurology, 2nd edition, revised. Baltimore: The Johns Hopkins Press.
Locock C (1857). Discussion of paper by E. H. Sieveking. Analysis of fifty-two cases of epilepsy observed by the author. Lancet 1:527–528.
Locock C (1857). Discussion of paper by E. H. Sieveking. Analysis of fifty-two cases of epilepsy observed by the author. Med Times Gazette 14:524–526.
Clouston TS (1868/1869). Experiments to determine the precise effect of bromide of potassium in epilepsy. J Ment Sci 14:305–321.
Coatsworth JJ (1971). Studies on the clinical efficacy of marketed antiepileptic drugs. NINDS Monograph 12. Washington, DC: U.S. Government Printing Office.
Special Projects Branch, CFR, NINDB, NIH. Annual Report. July 1, 1966 through June 30, 1967, unpublished.
Special Projects Branch, CFR, NINDB, NIH. Annual Report. July 1, 1967 through June 30, 1968, unpublished.
Browne TR, Dreifuss FE, Dyken PR, et al. (1975). Ethosuximide in the treatment of absence (petit mal) seizures. Neurology 25:515–524.
Gastaut H, Caveness WF, Landolt H, et al. (1964). A proposed international classification of epileptic seizures. Epilepsia 5:297–306.
Commission on Classification and Terminology of the International League Against Epilepsy (1981). Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:409–501.
U.S. Food and Drug Administration (1988). Guideline for the monitoring of clinical investigations. Docket No. 82D–0322. January, unpublished.
Nightingale SL (1988). New FDA guideline for the monitoring of clinical investigations. JAMA 259:3231.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Cereghino, J.J. (1990). Perspective of the Coordinating Center. In: Porter, R.J., Schoenberg, B.S. (eds) Controlled Clinical Trials in Neurological Disease. Foundations of Neurology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1495-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1495-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8804-6
Online ISBN: 978-1-4613-1495-0
eBook Packages: Springer Book Archive